Clinical Trial

Predictors of Drug Resistant Epilepsy Among Pediatric Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
1. This study aims to determine the main predictors of drug resistance in pediatric epilepsy by examining clinical data, EEG abnormalities, and neuroimaging results, in order to support early identification of resistant cases and improve treatment strategies . 2. Early introduction of new lines of treatment in case of refractory epilepsy as : Ketogenic diet , Rituximab and solumedrol
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-17.
Trial Details
NCT Number NCT07241754
Lead Sponsor Assiut University
Conditions Epilepsy, Seizure, Resistance
Enrollment 200 participants
Start Date 2025-12-29
Primary Completion 2026-12-29 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-17